Amiloride and Lithium Interaction

Drug interaction information between Amiloride and Lithium.

Amiloride and Lithium have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Amiloride and Lithium. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Amiloride

Potassium-Sparing Diuretic

Drug B

Lithium

Mood Stabilizer

How They Interact

Amiloride makes it harder for your kidneys to get rid of lithium. This can cause lithium to reach toxic levels in your body.

FDA Label Information

Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity. Read circulars for lithium preparations before use of such concomitant therapy.

Frequently Asked Questions

What SPL severity band is on file for Amiloride + Lithium?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Lithium has 90 labeled pairs on file vs Amiloride's 19. In the moderate band specifically: Amiloride has 7 (also Cyclosporine, Amlodipine/Benazepril, Benazepril, Perindopril); Lithium has 23 (also Amiodarone, Amlodipine/Valsartan, Azilsartan, Benazepril).

What mechanism field is on file for Amiloride and Lithium?

Amiloride makes it harder for your kidneys to get rid of lithium. This can cause lithium to reach toxic levels in your body.

Lithium carries more major-labeled pairs than Amiloride

SPL source-record counts only. This page's band is moderate · classes on file: Amiloride (Potassium-Sparing Diuretic); Lithium (Mood Stabilizer).

Lithium has 2 major-labeled pairs vs Amiloride's 1. This page itself is in the moderate band, not the major band.

Amiloride

1 major · 7 moderate · 11 minor · 19 total

Lithium

2 major · 23 moderate · 65 minor · 90 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.